Advertisement Terumo and Maquet Cardiovascular settle patent litigations - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Terumo and Maquet Cardiovascular settle patent litigations

Terumo, a healthcare company, and its subsidiary, Terumo Cardiovascular Systems, have announced an agreement to settle all outstanding litigation with Maquet Cardiovascular, a provider of medical technology solutions.

Under the terms of the agreement, all pending disputes between the companies will be immediately dismissed. In addition, the companies have agreed to cross license certain patents.

The companies have a number of lawsuits pending in which each claims the other has infringed its patents. The litigations all involve methods and devices used in endoscopic vessel harvesting.